First Trust Advisors
ROIV icon

First Trust Advisors’s Roivant Sciences ROIV Stock Holding History

First Trust Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Buy
468,623
+12,758
+3% +$377K 0.01% 1000
2026
Q1 		$12.6M Buy
455,865
+195,101
+75% +$5.01M 0.01% 1013
2025
Q4 		$5.66M Buy
260,764
+244,607
+1,514% +$4.83M ﹤0.01% 1340
2025
Q3 		$244K Sell
16,157
-2,358
-13% -$29.2K ﹤0.01% 2459
2025
Q2 		$209K Sell
18,515
-2,119,679
-99% -$23M ﹤0.01% 2514
2025
Q1 		$21.6M Sell
2,138,194
-307,202
-13% -$3.32M 0.02% 847
2024
Q4 		$28.9M Sell
2,445,396
-561,219
-19% -$6.64M 0.03% 727
2024
Q3 		$34.7M Sell
3,006,615
-527
-0% -$6K 0.03% 623
2024
Q2 		$31.8M Buy
3,007,142
+1,290,584
+75% +$14.1M 0.03% 632
2024
Q1 		$18.1M Sell
1,716,558
-1,022,880
-37% -$11M 0.02% 836
2023
Q4 		$30.8M Buy
2,739,438
+2,227,192
+435% +$21.7M 0.03% 583
2023
Q3 		$5.98M Buy
512,246
+336,331
+191% +$3.8M 0.01% 1152
2023
Q2 		$1.77M Sell
175,915
-78,581
-31% -$703K ﹤0.01% 1773
2023
Q1 		$1.88M Buy
+254,496
New +$2.1M ﹤0.01% 1707

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

First Trust Advisors's ROIV Position: Q2 2026 in Review

First Trust Advisors increased its Roivant Sciences (ROIV) stake by 2.8% in Q2 2026, buying an estimated $377K and bringing the position to 468,623 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #1000.

First Trust Advisors first reported a position in ROIV in Q1 2023 and has held it in 14 quarters since. The position peaked at $34.7M in Q3 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • First Trust Advisors held 468,623 shares of Roivant Sciences worth $16.6M as of Q2 2026.
  • First Trust Advisors bought 12,758 Roivant Sciences shares in Q2 2026, an estimated $377K.
  • Roivant Sciences made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1000 holding.
  • First Trust Advisors first reported a position in Roivant Sciences in Q1 2023 and has held it in 14 quarters since.
  • First Trust Advisors's Roivant Sciences position peaked at $34.7M in Q3 2024.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.